» Articles » PMID: 35831734

Three-Dimensional Near-Infrared Specimen Mapping Can Identify the Distance from the Tumor to the Surgical Margin During Resection of Pulmonary Ground Glass Opacities

Overview
Publisher Springer
Date 2022 Jul 13
PMID 35831734
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lung cancers can recur locally due to inadequate resection margins. Achieving adequate margin distances is challenging in pulmonary ground glass opacities (GGOs) because they are not easily palpable. To improve margin assessment during resection of GGOs, we propose a novel technique, three-dimensional near-infrared specimen mapping (3D-NSM).

Methods: Twenty patients with a cT1 GGO were enrolled and received a fluorescent tracer preoperatively. After resection, specimens underwent 3D-NSM in the operating room. Margins were graded as positive or negative based upon fluorescence at the staple line. Images were analyzed using ImageJ to quantify the distance from the tumor edge to the nearest staple line. This margin distance calculated by 3D-NSM was compared to the margin distance reported on final pathology several days postoperatively.

Results: 3D-NSM identified 20/20 GGOs with no false positive or false negative diagnoses. Mean fluorescence intensity for lesions was 110.92 arbitrary units (A.U.) (IQR: 77.77-122.03 A.U.) compared to 23.68 A.U. (IQR: 19.60-27.06 A.U.) for background lung parenchyma (p < 0.0001). There were 4 tumor-positive or close margins in the study cohort, and all 4 (100%) were identified by 3D-NSM. 3D-NSM margin distances were nearly identical to margin distances reported on final pathology (R = 0.9362). 3D-NSM slightly under-predicted margin distance, and the median difference in margins was 1.9 mm (IQR 0.5-4.3 mm).

Conclusions: 3D-NSM rapidly localizes GGOs by fluorescence and detects tumor-positive or close surgical margins. 3D-NSM can accurately quantify the resection margin distance as compared to formal pathology, which allows surgeons to rapidly determine whether sublobar resection margin distances are adequate.

Citing Articles

A Phase 2 Multicenter Clinical Trial of Intraoperative Molecular Imaging of Lung Cancer with a pH-Activatable Nanoprobe.

Kennedy G, Azari F, Chang A, Bou-Samra P, Desphande C, Predina J Mol Imaging Biol. 2024; 26(4):585-592.

PMID: 38992245 DOI: 10.1007/s11307-024-01933-x.

References
1.
Kennedy G, Newton A, Predina J, Singhal S . Intraoperative near-infrared imaging of mesothelioma. Transl Lung Cancer Res. 2017; 6(3):279-284. PMC: 5504116. DOI: 10.21037/tlcr.2017.05.01. View

2.
Tipirneni K, Warram J, Moore L, Prince A, de Boer E, Jani A . Oncologic Procedures Amenable to Fluorescence-guided Surgery. Ann Surg. 2017; 266(1):36-47. PMC: 6280663. DOI: 10.1097/SLA.0000000000002127. View

3.
Low P, Henne W, Doorneweerd D . Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 2007; 41(1):120-9. DOI: 10.1021/ar7000815. View

4.
Kennedy G, Azari F, Bernstein E, Nadeem B, Chang A, Segil A . A Prostate-Specific Membrane Antigen-Targeted Near-Infrared Conjugate for Identifying Pulmonary Squamous Cell Carcinoma during Resection. Mol Cancer Ther. 2022; 21(4):546-554. PMC: 8983600. DOI: 10.1158/1535-7163.MCT-21-0821. View

5.
Azari F, Kennedy G, Bernstein E, Hadjipanayis C, Vahrmeijer A, Smith B . Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt. 2021; 26(5). PMC: 8126806. DOI: 10.1117/1.JBO.26.5.050901. View